Man Group
ANAB icon

Man Group’s AnaptysBio ANAB Stock Holding History

Man Group’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,859
Closed -$394K – 2242
2025
Q3 		$394K Buy
+12,859
New +$295K ﹤0.01% 1921
2021
Q1 		– Sell
-63,113
Closed -$1.36M – 1844
2020
Q4 		$1.36M Sell
63,113
-47,770
-43% -$1.16M 0.01% 1322
2020
Q3 		$1.64M Buy
110,883
+20,044
+22% +$362K 0.01% 1251
2020
Q2 		$2.03M Sell
90,839
-15,811
-15% -$289K 0.01% 1062
2020
Q1 		$1.51M Sell
106,650
-42,633
-29% -$647K 0.01% 989
2019
Q4 		$2.43M Buy
+149,283
New +$3.53M 0.01% 1277
2019
Q2 		– Sell
-3,557
Closed -$260K – 1875
2019
Q1 		$260K Buy
+3,557
New +$246K ﹤0.01% 1839
2018
Q4 		– Sell
-5,374
Closed -$536K – 1903
2018
Q3 		$536K Buy
+5,374
New +$446K ﹤0.01% 1822

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Man Group's ANAB Position: Q4 2025 in Review

Man Group sold out of AnaptysBio (ANAB) in Q4 2025, closing a stake of 12,859 shares — an estimated $394K sold.

Man Group first reported a position in ANAB in Q3 2018 and held it in 8 quarters. The position peaked at $2.43M in Q4 2019. 179 funds tracked by Wall St. Rank hold ANAB as of Q4 2025.

  • Man Group reported no remaining AnaptysBio position as of Q4 2025 after selling out during the quarter.
  • Man Group sold 12,859 AnaptysBio shares in Q4 2025, an estimated $394K.
  • Man Group first reported a position in AnaptysBio in Q3 2018 and held it in 8 quarters.
  • Man Group's AnaptysBio position peaked at $2.43M in Q4 2019.
  • 179 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2025.

Based on Man Group's 13F filing for Q4 2025, filed 17 Feb 2026.